Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
Mailey L. Wilks, DNP, APRN, NP-C
From Cleveland Clinic Cancer Institute, Ohio
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):253–256 |
© 2022 Harborside™
Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anticoagulants, with a focus on direct oral anticoagulants, and what advanced practitioners should know about the prevention and the treatment of venous thromboembolism.
For access to the full length article, please sign in